Conservative treatment od endometriosis

Martin Trhlík
In: Klinická farmakologie a farmacie · 2025 · vol. 39(2) , pp. 117–121 · doi:10.36290/far.2025.040 · W4412035783
article OA: diamond CC0
📄 Open PDF View on OpenAlex View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-10 ⓘ

This paper reviews conservative treatment options for endometriosis, including analgesics, progestins, combined hormone therapy, GnRH agonists, and GnRH antagonists, highlighting the efficacy of estrogen-progestin combined with GnRH antagonists.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-06, 2026-06-10 ⓘ

The paper is a 2025 narrative review describing conservative (non-surgical) management of endometriosis, focusing on the use of analgesics and hormonal therapies, including combined estrogen–progestin contraception, progestins, and GnRH agonists/antagonists. It summarizes that the key goal of conservative pharmacotherapy is symptom relief—especially pelvic pain and dysmenorrhea—by suppressing ovulatory cycling and reducing activity in endometriotic lesions, while acknowledging that it does not cure the disease and is generally symptomatic with effects after discontinuation. A stated caveat is that treatment selection depends on pain severity, contraindications, tolerability, and fertility goals, and that long-term NSAID use can be limited by adverse effects such as gastrointestinal issues, renal concerns, and cardiovascular risk. This paper is centrally about endometriosis — it reviews conservative treatment options (analgesics, progestins, combined hormonal contraception, and GnRH agonists/antagonists) for controlling symptoms and lesion activity.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Endometriza je chronick gynekologick onemocnn postihujc a 10 % ensk populace ve fertilnm vku. Poruchy plodnosti, bolesti a orgnov postien zsadn ovlivuj kvalitu ivota a zdrav postiench. Socioekonomick dopad je znan a jsou vynakldny znan prostedky na lbu. Lba zahrnuje jak radikln - operan pstup, tak konzervativn, tj. podn rznch skupin liv. Analgetik za elem ovlivnn bolestivch projev a hormonlnch ppravk ze skupiny samotnch progestin, resp. v kombinaci s estrogeny, kter ovlivuj aktivitu endometriznch loisek. Dal skupinou modernch liv, kter se uplatuj v konzervativn lb endometrizy jsou GnRH agonist a GnRH antagonist. Pedevm podn GnRH antagonist doplnn o kombinaci estrogen-progestin pat mezi nejefektivnj monosti lby. V lnku jsou dle uvedeny dal monosti alternativn lby a naznaena budoucnost vvoje konzervativnch monost lby endometrizy a jej diagnostiky.

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (4)

References (9)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK